Loading clinical trials...
Loading clinical trials...
Efficacy of Intra-ureteric Aminophylline Instillation on Flexible Ureteroscopy Procedure: A Randomized Controlled Study
in this study we are going to evaluate the efficacy of intra-ureteric aminophylline instillation in facilitating ureteric access sheath placement prior to flexible ureteroscopy in reducing ureteric injury rates.
Urolithiasis (kidney and ureteral stones) is a common urologic condition with increasing prevalence. Flexible ureteroscopy (FURS) is a minimally invasive technique widely used for upper ureteric and renal stones. Aminophylline, a methylxanthine derivative, has been shown to relax smooth muscles and was previously used intravesically to facilitate rigid ureteroscopy with reduced complications. This study aims to assess whether intra-ureteric aminophylline instillation improves the ease of ureteral access sheath (UAS) placement during FURS and reduces ureteric injuries. patients will be divided into 3 groups: 1. Group A (Aminophylline Group): Intra-ureteric instillation of aminophylline 2. Group B (Ureteral Dilator Group): Traditional ureteral dilators 3. Group C (Combination Group): Aminophylline instillation + Ureteral dilators follow up of the patients will be through the success rate or failure of ureteric access sheath placement, operative time, bleeding, intra/postoperative complications and stone clearance (3-week follow-up with CT scan)
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
Yes
Ain Shams University Hospitals
Cairo, Abassia, Egypt
Start Date
March 1, 2025
Primary Completion Date
January 1, 2026
Completion Date
February 1, 2026
Last Updated
June 12, 2025
129
ESTIMATED participants
Usage of Aminophylline prior to ureteric dilatation in Flexible uretroscopy
DRUG
Sequential teflon dilator usage prior to ureteric access sheath placement in flexible uretroscopy
DEVICE
Aminophylline instillation and Ureteral dilators together
OTHER
Lead Sponsor
Ain Shams University
NCT07076589
NCT07155005
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions